In February 2022, the 46-year-old from New Jersey had prediabetes and high blood pressure when his doctor asked if he had considered trying a GLP-1 medication. She prescribed him Wegovy ...

“Programming at IFT FIRST has always been intentionally designed to encourage the constructive exchange of information and ...

Cutting off research funding for Harvard University might hurt the school, its president Alan Garber told NPR, but it also ...

A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...

May 22 (Reuters) - Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's (NOVOb.CO), opens new tab Ozempic may modestly reduce the risk of obesity-related cancers, especially ...

This story mentions weight, weight loss, and/or prescription GLP-1 drugs, which are FDA-approved ... Discover new workout ideas, healthy-eating recipes, makeup looks, skin-care advice, the best ...

But the pause brought renewed attention to one of the biggest challenges in health care today, one that played a role in GIC’s woes: the high price of popular GLP-1 drugs to treat obesity.

Hi, Carolyn: After spending my entire adult life fighting my weight and being medically classified as overweight, then obese, I have finally found some success with the new GLP-1 weight loss drugs.

Investigators examined GLP-1 receptor agonist real-world effectiveness and safety in kidney transplant recipients with diabetes.

GLP-1 drugs “alter taste perception” and "disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren’t as impressive as those promised ...